Retlich_2010_Clin.Pharmacokinet_49_829

Reference

Title : Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects - Retlich_2010_Clin.Pharmacokinet_49_829
Author(s) : Retlich S , Duval V , Ring A , Staab A , Huttner S , Jungnik A , Jaehde U , Dugi KA , Graefe-Mody U
Ref : Clinical Pharmacokinetics , 49 :829 , 2010
Abstract : Retlich_2010_Clin.Pharmacokinet_49_829
ESTHER : Retlich_2010_Clin.Pharmacokinet_49_829
PubMedSearch : Retlich_2010_Clin.Pharmacokinet_49_829
PubMedID: 21053992

Related information

Citations formats

Retlich S, Duval V, Ring A, Staab A, Huttner S, Jungnik A, Jaehde U, Dugi KA, Graefe-Mody U (2010)
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects
Clinical Pharmacokinetics 49 :829

Retlich S, Duval V, Ring A, Staab A, Huttner S, Jungnik A, Jaehde U, Dugi KA, Graefe-Mody U (2010)
Clinical Pharmacokinetics 49 :829